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Objective: The Durham Diabetes Coalition (DDC) was established in response to escalating rates of
disability and death related to type 2 diabetes mellitus, particularly among racial/ethnic minorities and
persons of low socioeconomic status in Durham County, North Carolina. We describe a community-based
demonstration project, informed by a geographic health information system (GHIS), that aims to improve
health and healthcare delivery for Durham County residents with diabetes.
Materials and Methods: A prospective, population-based study is assessing a community intervention
that leverages a GHIS to inform community-based diabetes care programs. The GHIS integrates clinical,
social, and environmental data to identify, stratify by risk, and assist selection of interventions at the
individual, neighborhood, and population levels.
Results: The DDC is using a multifaceted approach facilitated by GHIS to identify the speciﬁc risk proﬁles
of patients and neighborhoods across Durham County. A total of 22,982 patients with diabetes in Durham
County were identiﬁed using a computable phenotype. These patients tended to be older, female, African
American, and not covered by private health insurance, compared with the 166,041 persons without
diabetes. Predictive models inform decision-making to facilitate care and track outcomes. Interventions
include: 1) neighborhood interventions to improve the context of care; 2) intensive team-based care for
persons in the top decile of risk for death or hospitalization within the coming year; 3) low-intensity
telephone coaching to improve adherence to evidence-based treatments; 4) county-wide communica-
tion strategies; and 5) systematic quality improvement in clinical care.
Conclusions: To improve health outcomes and reduce costs associated with type 2 diabetes, the DDC is
matching resources with the speciﬁc needs of individuals and communities based on their risk characteristics.
 2015 The Authors. Published by Elsevier Inc. This is an open access article under the CC BY-NC-ND
license (http://creativecommons.org/licenses/by-nc-nd/3.0/).ARE, Case management of AIDS and Addiction through Resources and Education; DDC, Durham Diabetes Coalition; DIO,
Decision Support Repository; eMERGE, Electronic Medical Records and Genomics; GHIS, geographic health information
, Ninth Revision; NHB, non-Hispanic black; NHW, non-Hispanic white; SUPREME-DM, Surveillance, Prevention, and
Squibb Foundation and the Center for Medicare & Medicaid Innovation (CMS grant number: 1C1CMS331018).
ty Health System, Durham, NC 27710, USA. Tel.: þ1 919 668 1367; fax: þ1 919 668 1366.
).
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More than 26 million Americans have diabetes mellitus, a
burden of disease that results in estimated costs of $US 245 billion
annually [1e3]. Numerous advances in therapeutic and behavioral
interventions over the past 20 years have improved the prevention,
detection, and treatment of diabetes [4e11], but the application of
these interventions has not been sufﬁciently widespread or equi-
tably distributed to all vulnerable populations. In addition, these
challenges are exacerbated by an epidemic of obesity that has
escalated the trajectory of diabetes diagnoses, disability, and death.
Disadvantaged populations bear a disproportionate burden of type
2 diabetes and its complications [3,7,12,13]. Within the United
States, an estimated 12.6% of non-Hispanic blacks (NHBs) and 11.8%
of Hispanics/Latinos over the age of 20 are diagnosed with type 2
diabetes, compared with just 7.1% of non-Hispanic white (NHW)
Americans over age 20.
Geographic disparities also exist: the prevalence of type 2 dia-
betes mirrors the rise in obesity and is most heavily concentrated in
the southeastern United Statesda geographic area that also shares
the highest national prevalence of stroke, hypertension, and phys-
ical inactivity. Further, even after accounting for changing diag-
nostic criteria, diabetes prevalence is increasing. For example,
diabetes diagnoses among North Carolinians grew from <2% in the
1960s to >9% in 2009. The Centers for Disease Control and Pre-
vention estimates that 9.8% of the 280,000 residents of Durham
County, North Carolina have been diagnosed with diabetes and that
another 2.2% have undiagnosed diabetes. This is in addition to
already high rates of obesity and overweight (29.6% and 34%,
respectively) among adults in the region [3].
Recognizing that physical, social, and environmental factors
shape the diabetes epidemic, and that reducing poor health out-
comes and potentially avoidable costs related to poorly controlled
type 2 diabetes will require innovative models of care and patient
engagement, a group of Durham County formed the Durham Dia-
betes Coalition (DDC) in 2011. The goals of the DDC are 1) to
improve population-level diabetes management, health outcomes,
and quality of life for diagnosed and undiagnosed adults living with
type 2 diabetes; and 2) to reduce disparities (including those based
on race, age, sex, socioeconomic status, and insurance status) in
diabetes management, health outcomes, and quality of life for
adults living with type 2 diabetes.
In this paper, we describe the strategies employed by the DDC,
including the project’s design, the initial phase of characterizing
and understanding the local diabetes problem, interventions
resulting from lessons learned during the initial phase, and
strengths and weaknesses affecting implementation of the project
and its assessment.
Materials and methods
Study area
Durham County is located in the Central Piedmont region of
North Carolina and is demographically distinct from the rest of the
state. Compared with North Carolina overall and with the United
States, Durham County has a larger proportion of NHBs. Educational
attainment is also higher: 86.9% of Durham County adults aged25
years have at least a high school diploma (vs. 84.5% for North Car-
olina; 85.7% for the United States) and 44.7% hold a bachelor’s de-
gree or higher (vs. 26.8% for North Carolina; 28.5% for the United
States) [14,15]. From 2008 to 2012, median household income in
Durham County was $50,997, exceeding the state median of
$46,450. However, educational attainment and socioeconomic
status are not evenly distributed in Durham County; during thesame interval, 18% of Durham residents lived below the poverty
level [14,15] vs. 16.8% for North Carolina and 14.9% for the United
States.
Engaged organizations
The DDC was founded to signiﬁcantly reduce death and disability
from type 2 diabetes countywide by 2017. The coalition comprises
members from the Duke University Health System (Duke Medicine),
Durham County Department of Public Health, National Center for
Geospatial Medicine at the University of Michigan, Lincoln Commu-
nity Health Center (LCHC; a Federally Qualiﬁed Health Center), and a
community advisory board representing 23 public, political, and pri-
vate community agencies. The DDC approach integrates detailed
geographic information systemswith existing electronic health record
(EHR) data to create a geographic health information system (GHIS)
that is combined with patient care and community-based approaches
using proven constructs from chronic disease care models. This
approach simultaneously addresses individual and community health
in our pursuit of the triple aim of improved health, improved health
care, and reduced costs [16].
Durham is home to Duke University and its afﬁliated health
system, including an academic hospital, a community hospital, and
a large number of outpatient clinics. Based on utilization data from
Duke Medicine and U.S. Census data on population in Durham
County, an estimated 80% of DurhamCounty residents received care
from a Duke Medicine provider at some point during the interval of
2007e2011. Lincoln Community Health Center and the Durham
County Department of Public Health also provide care to Durham
County residents, and the three institutions together touch almost
every resident of Durham County. An important element of the DDC
is the weaving together of data sources, analytics, and strategies
across these entities that account for the overwhelming majority of
healthcare delivery in Durham County.
Clinical data
The primary source of clinical data for this project is the Duke
Enterprise Data Warehouse (DEDW). The DEDW integrates EHRs
containing clinical data (laboratory, diagnostic, clinical notes, tests,
etc.) as well as administrative and ﬁnancial data from clinical en-
counters across the health system, including more than 25 major
clinical and ﬁnancial systems within the institution. Social and
environmental data come from a wide variety of sources, detailed
below.
Geographic health information systems
Geographic health information systems (GHISs) [17e19] are
used to build large-scale spatial data architectures that connect
data from EHRs with social and environmental data from the
communities where patients reside. These systems use geographic
information such as patient addresses or neighborhood locations to
connect previously unrelated datasets. The resulting spatial data
architecture allows us to understand patients both on the basis of
their medical records and the context of their surroundings, thus
affording a data-driven capacity to identify geographic areas in
which individuals are at particular risk of poor outcomes. These
geographic areas can be as small or as large as is useful to the or-
ganizations working within them.
In this project, patient addresses taken from EHRs are geocoded
by associatingmedical record informationwith a particular physical
locationdspeciﬁcally, an individual tax parcel in Durham County.
Because we have extensive experience working with health records
and with NC and Durham County tax parcel data, we were able to
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non-geocodable data such as incomplete addresses and post ofﬁce
boxes, our match rate is 88%. Although we typically achieve match
rates well above 90% with North Carolina administrative datasets,
the quality and completeness of EHR address information pre-
vented us from attaining similar match rates for this project.
To obtain high-quality matches, we perform a three-batch
matching process using Esri ArcGIS 10.1 software (Redlands, CA).
First, raw addresses from the EHR are matched against StreetMap
North America data with a match score requirement of 100/100 for
Batch 1. Remaining unmatched addresses are standardized (for
example, “Street,” “Str”, and “STR” are all standardized to “ST”) and
then re-run against the StreetMap North America datawith amatch
score of 90/100 for Batch 2. Remaining unmatched addresses are
matched manually at the geocoder’s discretion for Batch 3. For the
present dataset, we achieved a match rate of 70.2% with Batch 1,
83% after incorporating Batch 2, and 84% after incorporating
Batch 3.
The DEDW assigns each patient a unique identiﬁer. Probabilistic
matching is done and individuals with multiple unique identiﬁers
are de-duplicated. Once geocoding is completed, we connect
medical record data to other variables including neighborhood
characteristics, census data, environmental data, community re-
sources, social stressors (e.g., poor housing quality or crime), access
to green spaces and areas for outdoor or indoor recreation and
exercise, and community and clinic-based health care resources, all
while leveraging rapidly evolving technologies and methods in GIS
that allow for better geocoding [20]. We tracked whether addresses
were matched in Batches 1, 2, or 3, allowing us to perform sensi-
tivity analyses on all subsequent models and test whether match
strength in geocoded data has an inﬂuence on model results and
performance.
Such linkages can lead to greater understanding of racial dis-
parities in health care outcomes [17]. Similarly, linking patient data
to neighborhood-level characteristics can describe patient pop-
ulations over space and time, potentially informing alternative
approaches to health care. However, linking EHR data to neigh-
borhood characteristic data presents a host of challenges. Our
research team has previously linked clinical data on pregnancy and
early childhood to neighborhood data in the same geography, and
to adult disease in a more extended geography, and are using the
same methods for this project [17,21e31]. Most importantly, this
type of spatial data architecture enables risk stratiﬁcation of in-
dividuals based on the integration of medical, social, and environ-
mental risk. This in turn affords the opportunity to examine the
spatial distribution of risk relative to venues for community and
clinic-based interventions and to use this knowledge in developing
individualized treatment plans.
Deﬁning type 2 diabetes using a “computable phenotype”
In order to assess the impact of type 2 diabetes within Durham
County, we ﬁrst identiﬁed affected patients through secondary data
analysis of the DEDW. Such identiﬁcation requires a deﬁnition or
phenotype that can be computed to correctly label patients or en-
counters with diabetes. To date, there are few published de-
scriptions of other institutions’ phenotypic deﬁnitions for diabetes
registries. The Electronic Medical Records and Genomics (eMERGE)
Consortium is focused on the genetics of complex phenotypes, and
its deﬁnition was speciﬁcally created to identify only patients with
type 2 diabetes for research purposes. It is therefore constructed to
exclude patients with type 1 diabetes mellitus codes [32] and to
return a low false-positive rate for type 2 diabetes diagnoses. The
Surveillance, Prevention, and Management of Diabetes Mellitus
(SUPREME-DM) project was established among institutions with aninterest in population health, similar to the goals of the DDC.
However, this group has a different EHR than that used by Duke and
uses different coding practices, requiring us to build and validate
our own phenotype [33].
The DDC began with a basic deﬁnition of diabetes based on In-
ternational Classiﬁcation of Diseases, Ninth Revision (ICD-9) diag-
nosis codes. This deﬁnitionwas supplemented by additional criteria
to identify patients who lacked a formal coded diagnosis but whose
clinical measures indicate that they have diabetes, as other groups
have done [32,33]. The DDC EHR diabetes phenotype deﬁnition
includes the adult Durham population of patients who met one or
more of the following criteria during a Duke Medicine encounter
between 2007 and 2011:
 One or more instances of the speciﬁed ICD-9-Clinical Modiﬁ-
cation (CM) diagnosis codes (250.xx [with the exclusion of
250.x1 and 250.x3], 249.xx, 357.2, 362.0x, 366.41) on any type of
encounter (inpatient, outpatient, emergency department);
 One ormore active medications associatedwith diabetesmellitus
treatment reported during outpatient medication reconciliation
(acarbose, acetohexamide, amylin agonists, chlorpropamide,
glucagon-like peptide-1 agonists, insulin, metformin, miglitol,
nateglinide, pioglitazone, repaglinide, rosiglitazone, sulfonyl-
ureas, tolazamide, troglitazone); and/or
 Two or more abnormal diabetes labs within a 365-day period
(hemoglobin A1c  6.5%; fasting glucose 126 mg/dL; random
glucose 200 mg/dL).
This deﬁnition was deliberately constructed to include persons
with undiagnosed or potential diabetes, persons with well-
controlled diabetes on single oral therapy, or those who see spe-
cialty providers who may not code all medical illnesses. A more
detailed discussion of this process has been published [34].
According to the U.S. Census, Durham County’s 2010 population
was 267,587, of whom 77.9% (208,450) were aged >18 years. The
DEDW contains data on 189,023 adult patients living Durham
County. Thus, we have data on >90% of adult Durham county res-
idents. We are almost certainly missing some patients with early,
noncomplicated, or undiagnosed diabetes, but patients requiring
inpatient or emergency evaluation are seen at Duke Medicine for a
supermajority of the population. Similarly, the vast majority of
outpatients are seen through Duke Medicine, LCHC, or the public
health system. The LCHC data will eventually be incorporated into
the system so that a comprehensive superset of data is available
across the county.
In addition to missing patients who may not seek health care,
Durham residents who both receive all of their health care outside
of the county and do not see providers employed by Duke are not
accounted for in our data set. We also lack follow-up data for pa-
tient who move out of Durham County and no longer see Duke
Medicine providers. As the project evolves and regional data ex-
change occurs, we expect to be able to quantify the degree of
missingness in our numbers, including follow-up of patients who
have not had contact with the system within the previous year.
Identifying high-risk areas and individuals
Given that we are able to identify patients with our clinical
deﬁnition of type 2 diabetes from our computable phenotype, we
have deployed GHIS tools to perform a series of tasks enabling a
detailed depiction of health status and an approach to directing
interventions at the individual, neighborhood, and county levels.
These tasks include: 1) developing and reﬁning risk algorithms; 2)
identifying high-risk individuals and sub-county geographies
where high-risk individuals cluster; and 3) identifying gaps in care,
Figure 1. Data and analysis work ﬂow. This schematic demonstrates the application of
the risk algorithm in practice. A regular data extract is coupled with the risk algorithm
and persons with type 2 diabetes are assigned a composite risk score that places them
on the intervention spectrum, from relatively low risk and lower-intensity, commu-
nity-based interventions to relatively high risk and higher-intensity, individually-based
interventions. Each diamond represents a patient; each color represents a different
geographic area. In this representation, multiple persons at high risk characterize the
blue neighborhood.
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and health care resources. The GHIS allows us to identify patients
on the basis of risk level matched with intensity of services, pro-
viders, and locations.
A logistic regression equation has been developed using
existing clinical data to predict risk for serious outcomes, deﬁned
as hospital/emergency department admission or death. The initial
algorithm predicts poor outcomes in calendar year 2011 based on
2010 EHR data, and then validates the model prediction using
2012 EHR data. Candidate variables were selected from proven risk
factors for poor outcomes in patients with diabetes reported in the
literature and suggested by expert clinician input. We then con-
structed a logistic regression model using an AIC-based backward
stepwise regression procedure. Of note, neighborhood data are not
used to construct the risk algorithm, but instead are used to design
subsequent intervention strategies. These initial efforts were
reported at the American Diabetes Association annual meeting in
2014 [31].
Because this work is conceived as a county-wide quality
improvement project, we will continuously improve the model by
including increasingly reﬁned clinical, neighborhood, and social data
as they become available. We also plan to develop predictive models
for speciﬁc diabetes-related outcomes that may have different pre-
dictors, such as amputation, stroke, and myocardial infarction.
Fig. 1 demonstrates how the risk algorithm works in practice. A
regular data extract is coupledwith the risk algorithm. Personswith
type 2 diabetes are assigned a composite risk score that places them
on the intervention spectrum, from relatively low risk and lower-
intensity, community-based interventions to relatively high risk
and higher-intensity, individually-based interventions. Each dia-
mond in Fig. 1 represents a patient, and each color represents a
different geographic area. Multiple individuals at high risk
(requiring a more intense intervention) characterize the blue
neighborhood, which would then serve as a logical target area for
more intense interventions. Assessments that combine risk
assessment with geographic distribution can be performed on the
entire patient population.Interventions
Our initial focus has been on patients in the high-risk group,
deﬁned as the upper 10% of risk for death or hospitalization in the
coming year. These patients receive an intensive, individually
tailored intervention that includes access to in-home intervention
via community health workers, or home visits by a health careteam. Moderate-risk patients receive individual telephone-based
interventions that support behavior change, focused community-
based programs, and provider-based health care. This stratiﬁca-
tion of interventions allows limited resources to be targeted for
maximal impact in the community.
To date, the DDC has identiﬁed 5 intervention strategies for this
project: 1) targeted intensive neighborhood interventions; 2)
intensive clinical care intervention to reach high-risk patients with
potential barriers to traditional clinical care; 3) low-intensity tele-
phone coaching to support moderate-risk patients in sustaining
change in health behavior; 4) community interventions applicable
to all Durham County residents; and 5) systematic change to clinical
care systems to improve adherence to rigorous evidence-based
diabetes care across Durham County.
Metrics and evaluation
Study data will enable multilevel examination across a range of
patient outcomes and experiences. Speciﬁc baseline indicators of
the prevalence of diabetes complications such as microvascular and
macrovascular comorbidities have been assessed at the onset of the
project and the system is updated periodically (Supplemental
Table S1). With each health-system encounter, new outcomes and
events are added to the DEDW, and these patterns can be examined
in aggregate and by sub-geographies. Guideline-based treatment
patterns for risk factors such as glycemic control, hypertension,
hypercholesterolemia, and tobacco abuse are assessed to evaluate
quality of care and identify pertinent quality-improvement initia-
tives. Patient-reported outcomes, including measures of depres-
sion, self-care, and medication adherence, are continuously
evaluated in the high-risk group and iteratively used to drive
treatment plans for high- and moderate-risk patients.
Health services utilization for diabetes-related events (such as
diabetes-related emergency department and hospital admissions)
and care episodes associated with quality care (such as primary care
visits, ophthalmology screens, and dietician visits) are recorded, and
these elements will be evaluated with the presumption that better
adherence to proven beneﬁcial care will improve outcomes, although
the direct reduction in clinical events is unlikely to be measurable,
because it can take years for a risk factor to change in ways that are
reﬂected in a reduction of major events such as death and myocardial
infarction. The system will be able to assign costs to these in-
terventions and interactions with the health system, thereby enabling
modeling of the value of the interventions. All-cause and diabetes-
and cardiovascular-speciﬁc mortality will also be reported.
The DDC will evaluate outcomes and the processes that led to
those outcomes as described in the logic model (Appendix), which
depicts the relationships between the planned work and the
intended results [35]. DDC interventions are designed to contribute
to both individual and population-based measures of health
improvement, such as improved self-management of diabetes,
improved access to care, and sustainable change in health and
healthcare delivery in Durham communities.
The DDC program evaluation will take place on 3 levels: 1) as
determined by individual risk, with a focus on high-risk patients
receiving the intensive clinical intervention; 2) the whole-
population level for determining the effects of the program on
diabetes-related health outcomes in Durham County; and 3) the
sub-county geography level to examine the impact of interventions
across demographically diverse areas.
Results
Using the computable phenotype described above, 22,982
unique patients with type 2 diabetes have been identiﬁed from the
Table 1
Prevalence of diabetes in Durham County, North Carolina
All Without
diabetes
With diabetes
N % N % N %
Total 189,023 166,041 87.8 22,982 12.2
Age (in years)
18e21 11,522 6.1 11,327 6.8 195 0.9
22e29 35,166 18.6 34,418 20.7 748 3.3
30e39 41,944 22.2 40,037 24.1 1907 8.3
40e49 31,362 16.6 28,174 17.0 3188 13.9
50e64 40,021 21.2 32,195 19.4 7826 34.1
65þ 29,008 15.4 19,890 12.0 9118 39.7
Race/ethnicity
Non-Hispanic white 83,483 44.2 74,586 44.9 8897 38.7
Non-Hispanic black 67,371 35.6 55,365 33.3 12,006 52.2
Hispanic 12,771 6.8 11,953 7.2 818 3.6
Asian 5731 3.0 5399 3.3 332 1.4
Other 6254 3.3 5793 3.5 461 2.0
Not reported 13,413 7.1 12,945 7.8 468 2.0
Sex
Female 108,204 57.2 95,072 57.3 13,132 57.1
Male 80,731 42.7 70,882 42.7 9849 42.9
Not reported 88 0.1 87 0.1 1 0.0
Insurance status
Private 114,515 60.6 105,236 63.4 9279 40.4
Medicaid/Medicare 41,401 21.9 30,093 18.1 11,308 49.2
Self-pay 27,782 14.7 25,485 15.4 2297 10.0
Not reported 5325 2.8 5227 3.2 98 0.4
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are older, more often female, less often insured with private in-
surance, and more often African American. Through the use of the
GHIS, these data have been mapped and geographically linked with
other key social and environmental factors (Fig. 2).
Characterizing the burden of diabetes
Fig. 3 displays the percentage of patients with type 2 diabetes
who reside in Durham County and are present in the DEDW (a), the
percentage of diabetes patients for whom no hemoglobin (Hb) A1c
measurement was available (b), and the percentage of diabetes
patients whose HbA1c measurements were outside of goal range
(>7%; c). These maps reveal spatial patterns in the prevalence of
diabetes, degree of success in achieving best practices (e.g., HbA1c
measurements are recommended every 6 months), and degree of
glycemic control in Durham County.
Fig. 3 maps a series of key community resources onto the pattern
of diabetes control from Fig. 2. This sample map highlights the
social context of health disparities. For example, Fig. 3 demon-
strates that some of the highest concentrations of diabetes occur in
neighborhoods without grocery stores or medical clinics.
Targeted interventions
General concepts of targeting
Targeted interventions occur at both individual and neighbor-
hood levels. We assumed that persons identiﬁed as high-risk would
beneﬁt from more intensive interventions. Many of these patients
have not beneﬁtted from proven interventions due to barriers to
care such as lack of access to food (or to healthful food), lack of
transportation, and inability to pay for all medications. Connecting
patients to medical, social, and ﬁnancial resources is an essential
part of our intervention for these high-risk patients.
Although neighborhood datawere not used to construct the ﬁrst
version of the risk algorithm and subsequently assign patients to
intervention groups, spatial information is used to make home-visitstrategies more efﬁcient and to connect high-risk individuals with
local resources. In addition, the moderate-risk intervention in-
cludes an analysis of how patients in this group cluster geograph-
ically, and how those clusters relate to local resources. This in turn is
used to iteratively reﬁne the moderate-risk intervention.
Neighborhood interventions
Neighborhood interventions are being piloted in 3 neighbor-
hoods in Durham County, chosen with the assistance of the DDC’s
community advisory board. These communities have been selected
using GHIS maps that analyze type 2 diabetes prevalence and
complications, socioeconomic factors, existing neighborhood re-
sources, and level of potential project impact. The Board helps
ensure that the DDC selects interventions that are culturally
appropriate, sustainable, and meet community needs.
Community health integrators (trained professional health ed-
ucators) are deployed to each targeted neighborhood to assess and
mobilize the community by building relationships with residents,
neighborhood leaders, and other stakeholders such as churches,
nonproﬁts, and community groups. Community interventions are
informed by feedback from these stakeholders and reﬂect each
neighborhood’s unique needs. Some community interventions are
furnishing Durham County residents with the tools and resources
they need to manage their diabetes and are fostering healthier
lifestyle habits through evidence-based initiatives such as the
Diabetes Self-Management Program and the Chronic Disease Self-
Management Program. Other interventions are changing the
actual environment by creating “Healthy Mile Trails” on sidewalks.
Community activities also provide community members with skill
building and health-education services such as Shopping Matters
grocery store tours, walking groups, diabetes presentations, webinars,
and a monthly educational community newsletter. In order to sustain
interventions and create permanent environmental changes, lay
leaders will be trained to work with neighborhood organizations to
write policies that promote health.
A health-departmentebased diabetes information and
communication ofﬁcer (DIO) uses GHIS data and community input
to develop outreach campaigns supporting and advertising neigh-
borhood and county interventions. The DIO provides the public
with information about DDC interventions and services, diabetes-
related health information, and local diabetes resources, including
a DDC website, DDC-speciﬁc social media sites (e.g., Facebook,
Twitter, YouTube), a television show aired on the local government
access cable channel, and various countywide media campaigns
that will encourage improved health behaviors for Durham County
residents. The DIOs are also responsible for creating a DDC brand to
foster name recognition in the community. The DIOs also work
closely with health educators to tailor health messages and brand
all DDC outreach materials.
These efforts enable continuous quality improvement and mid-
course corrections based on both real-time GHIS data and commu-
nity feedback on the short- and long-term impact of interventions.
Intensive clinical care intervention
An intensive, in-home clinical care program is offered for pa-
tients identiﬁed by the risk algorithm as being within the top 10% in
terms of risk for death or hospitalization in the coming year. Each
clinical team is supervised by a clinical endocrinologist and in-
cludes nurse practitioners, a community health worker, a registered
dietician, and a licensed clinical social worker. The clinical inter-
vention is based on the “Just for Us” clinical program [36] managed
by the Duke Division of Community Health and Lincoln Community
Health Center, which offers in-home medical services to older
adults and adults with disabilities in Durham’s public and subsi-
dized housing facilities.
Figure 2. Durham resources and diabetes control. This map of the central area of the city of Durham in Durham County displays patient data that have been mapped and
geographically linked with key social and environmental factors through the application of the geographic health information system.
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physicians to ensure that all care providers are aware of team
goals and each patient’s progress. The high-risk clinical team
also helps coordinate care for moderate-risk patients by
communicating with their existing medical home providers and
using centralized telephone coaching modules [37] implemented
by the team of community health workers at the Durham
County Department of Public Health and Healing with CAARE,
Inc. The clinical intervention team tracks patient progress
through ongoing monitoring of patient data at 6-month in-
tervals. The intervention suite provides a coordinated approach
to achieving sustainable improvements in self-management in
the high-risk population, preventing unnecessary hospitalization
and emergency department use.County-wide community interventions
Successful interventions for managing chronic illness integrate
community resources and policies with health system organiza-
tional structure [38,39] and depend upon shared systems for
exchanging clinical information, decision support, design of care
delivery, and self-management support. By integrating resources,
communities and health systems can foster communication and
productive interactions between patients and providers, leading to
improved clinical outcomes. The GHIS expands our ability to direct
resources where they are needed by providing a more complete
picture of risk factors within a neighborhood context and targeting
health messages to the community using map displays. We are
leveraging the existing structures and missions of the Durham
County Department of Public Health, houses of worship, and
a b c
Figure 3. Duke diabetes patients, 2007e2011. This ﬁgure displays the percentage of patients with type 2 diabetes who reside in Durham County and are present in the Duke
Enterprise Data Warehouse (a), the percentage of diabetes patients for whom no hemoglobin (Hb) A1c measurement was available (b), and the percentage of diabetes patients
whose HbA1c measurements were outside of goal range (>7%) (c).
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with CAARE, Inc., the American Diabetes Association, the North
Carolina county extension ofﬁce, and numerous other community
organizations. Using this network, we are conducting health fairs
and media events and promoting policy decisions that improve the
social and physical environment to make health management
easier for patients living with diabetes in Durham County.
Systematic changes to clinical care
In order to improve rigorous, evidence-based diabetes care
throughout Durham County, we are working with Durham County
providers to implement guidelines-based care for all patients with
type 2 diabetes through EHR systems using care protocols, best
practice alerts, and risk category alerts based on individual and
neighborhood characteristics. The initial suite of care protocols
emphasizes 1) glycemic control through nutrition, physical activity,
and medication management; 2) treatment of hypertension,
including appropriate use of blood pressure medications; 3) treat-
ment of hypercholesterolemia and cardiovascular risk, including
use of statins when appropriate; and 4) telephone coaching to
improve adherence to evidence-based treatments. In its full form,
this will be accomplished by implementing diabetes care protocols
and quality score cards across locations, training the workforce in
patient-centered care and motivational interviewing, as well as
creating virtual visits to review medications, glucose and blood
pressure readings, and achievement of patient goals [40,41].
Limitations
The DDC is a quality improvement project implemented at the
population level of a county. As such, it is continuously evolving as
improvements aremade to the data systems linking elements of thehealth delivery systems and as interventions are adapted based on
data and community feedback. Because we lack a randomized
comparison group, we cannot draw deﬁnitive causal inferences
regarding trends over time in diabetes outcomes and costs. We are
currently developing approaches for assessing outcomes that
include causal inference modeling and non-randomized compari-
son to other counties.
Movement of populations into and out of both Durham County
and the Duke Medicine health system presents challenges to our
ability to determine the effectiveness of this project. In addition,
continuous changes to the racial, ethnic, and socioeconomic
makeup of communities may correspondingly alter risk proﬁles for
individuals and neighborhoods.
Although we have identiﬁed individuals and neighborhoods
across the entire spectrum of risk for negative outcomes from
diabetes, determining which interventions would be most effective
at reducing risk remains challenging. The results of population in-
terventions have been mixed [42e46] and there is no single proven
approach, although some concepts seem to be central to health
improvement. Our intervention complements traditional medical
approaches by addressing substance abuse, violence, psychiatric
illness, inability to pay for medications, lack of access to food, and
homelessness. However, we acknowledge that there are currently
few examples of successful interventions across multiple di-
mensions. Nonetheless, we believe identifying patients and
neighborhoods with gaps in care and developing interventions to
address these gaps will be the best way to improve outcomes.
Diabetes control, and therefore diabetes complications, are
affected by the ability to self-manage diabetes through a healthful
lifestyle; thus, access to places to walk, exercise, and ﬁnd healthful
food are essential. Some studies have suggested that coordinated
S.E. Spratt et al. / Journal of Clinical & Translational Endocrinology 2 (2015) 26e36 33care for high-risk patients is not always successful [42e44]. For this
reason, we have combined coordinated care with geospatial anal-
ysis that can ultimately inform individual, population, and
governmental policies.
Conclusions
The DDC is pursuing a strategy to improve diabetes outcomes at
the individual, neighborhood, and population levels using in-
terventions consonant with the “triple aim” of improved experi-
ence of care, improved health outcomes, and lower utilization
[16,45]. By enabling risk stratiﬁcation of patients and neighbor-
hoods, GHISs are being used to assist decision-making and evalu-
ation of interventions and clinical care. GHISs are also used to
efﬁciently focus limited resources by identifying communities in
need of higher-intensity interventions and providing continuous
monitoring of individuals and populations. By coordinating and
integrating clinical care within the community, we aim to improve
health care delivery and health outcomes for both individuals and
populations while simultaneously reducing preventable complica-
tions, procedures, and admissions. This system will provide the
platform for monitoring and evaluating the initial implementation
of coordinated care for high-risk groups and community-wide in-
terventions. Lessons learned will contribute to knowledge needed
that we hope will create a sustainable and replicable platform to be
implemented in the southeastern United States and other areas
disproportionately affected by diabetes.
Key points
 The diabetes epidemic is a physically and ﬁnancially costly
burden.
 Known therapies to improve diabetes outcomes have not been
equally applied to all populations.
 Matching resources to individuals and communities based on
risk may improve health outcomes.
 Geographic disparities in diabetes prevalence and complications
exist.
 A geographic health information system can inform community-
based diabetes care programs.
 Social and environmental factors affect diabetes care and out-
comes as much as medical factors.
 Combining community and clinical approaches of varying in-
tensities is being used to impact death and disability from
diabetes.
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Supplemental Table S1
Outcome measures
Domain Outcome measure Process measure Population
prevalence
Intervention
cohort
incidence
Microvascular
complications
Kidney disease e classiﬁcation
 Microalbuminuria
 Macroalbuminuria
 CKD 3, 4, and 5
Kidney disease e process/
quality care
 Monitoring
 Guideline medication use
X X
Dialysis X X
Peripheral neuropathy Process/quality care
 Foot exam
X X
Retinopathy e classiﬁcation
 NPDR vs. PDR
Retinopathy e process/quality care
 Yearly eye exam
X X
Wound/skin ulcer treatment e classiﬁcation
 Location
 Type
Wound/skin ulcer treatment e
process
 Foot exam
 Ankle brachial indices
X X
Macrovascular
complications
Amputation procedures e classiﬁcation
 Location (i.e., R BKA)
Amputation procedures e process/
quality care
 Foot exam
 Ankle e brachial indices
X X
Acute MI events Guideline medication use X X
Stroke events Guideline medication use X X
Coronary revascularization procedures Guideline medication use X X
Heart failure Guideline medication use X X
Diabetes control Hemoglobin A1c:
 Degree of control
Hemoglobin A1c e process/quality
care
 A1c monitoring
 Guideline medications
X X
Glucose  Blood glucose monitoring X X
Hypoglycemia events X X
Hyperglycemia events X X
Hyperosmolar X X
Ketoacidosis X X
Risk factors Obesity Weight, diet, activity monitoring X X
Hypertension
 Degree in control
 Guideline medications
Hypertension
 Process of BP monitoring
X X
Hyperlipidemia
 Degree in control
 Guideline medication use
Hyperlipidemia
 Process of monitoring
X X
Smoking status (Fagerstrom test for Nicotine Dependence) Smoking cessation program
attendance
X
Exercise status (Stanford scale) Activity monitoring X
Patient-reported outcomes Global health scale score (PROMIS-9) Survey completion rate X
Patient depression score (PHQ-2) Survey completion rate X
mDiabetes care proﬁle score (patient perception of self-
management skills)
Survey completion rate X
Medication adherence score (Morisky) Survey completion rate X
Health services utilization Emergency department encounters (DM-related
and non-DM related
X X
Inpatient encounters (DM-related,
cardiovascular-related, and other)
X X
Outpatient encounters
 Primary care
 Endocrinology
 CDE
 RD
X X
Length of stay for inpatient admissions X X
Billing charges for health services X
Prediction of adverse
outcomes
SEDI risk algorithm scoring X X
Death Mortality status X X
BP, blood pressure; CDE, Certiﬁed Diabetes Educator; CKD, chronic kidney disease; DM, diabetes mellitus; MI, myocardial infarction; NPDR, nonproliferative diabetic reti-
nopathy; PDR, proliferative diabetic retinopathy; RD, Registered Dietitian; SEDI, Southeast Diabetes Initiative.
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